Upadacitinib and ustekinumab combination treatment for a refractory case of spondyloarthritis and Crohn's disease.

Authors	Elena Bianchi, Anna Paola Pata, Luca Cantarini, Bruno Frediani, Stefano Gentileschi
Journal	Clinical and experimental rheumatology (Clin Exp Rheumatol) Vol. 42 Issue 3 Pg. 766 (Mar 2024) ISSN: 0392-856X [Print] Italy
PMID	37812461 (Publication Type: Letter)
Chemical References	Ustekinumab upadacitinib Heterocyclic Compounds, 3-Ring
Topics	Humans Ustekinumab (therapeutic use) Crohn Disease (diagnosis, drug therapy) Heterocyclic Compounds, 3-Ring Spondylarthritis (drug therapy) Treatment Outcome Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!